https://www.marketscreener.com/quote/stock/REGULUS-THERAPEUTICS-INC-46475580/news/Regulus-Therapeutics-Announces-Top-Line-Data-from-the-First-Cohort-of-Phase-1b-Clinical-Trial-of-RGL-33410818/?utm_source=telegram&utm_medium=social&utm_campaign=share